Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Sep 15, 2025
4 Sep 8, 2025
SCHEDULE 13D/A Sep 8, 2025
SCHEDULE 13D/A Sep 8, 2025
4 Sep 8, 2025
8-K Sep 3, 2025 8-K
424B5 Sep 3, 2025 424B5
S-3MEF Sep 2, 2025 S-3MEF
8-K Sep 2, 2025 8-K
424B5 Sep 2, 2025 424B5
4 Aug 14, 2025 FORM 4
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
144 Aug 13, 2025
10-Q Aug 12, 2025 10-Q
8-K Aug 12, 2025 8-K
4 Jul 30, 2025 FORM 4
144 Jul 30, 2025
144 Jul 30, 2025
144 Jul 28, 2025
4 Jul 15, 2025 FORM 4
4 Jul 15, 2025 FORM 4
4 Jul 15, 2025 FORM 4
144 Jul 14, 2025
144 Jul 11, 2025
← Newer Page 7 of 17 · 406 filings Older →